Drug Catalog - Product Detail
FLURANDRENOLIDE LOTION 0.05% 120ML
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 24470-0921-12 | CINTEX | 120 | 0.05% | NA |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
Description Flurandrenolide, USP is a potent corticosteroid intended for topical use. Flurandrenolide occurs as white to off-white, fluffy, crystalline powder and is odorless. Flurandrenolide is practically insoluble in water and in ether. One g dissolves in 72 mL of alcohol and in 10 mL of chloroform. The molecular weight of flurandrenolide is 436.52. The chemical name of flurandrenolide is Pregn-4-ene-3, 20-dione, 6-fluoro-11, 21-dihydroxy-16, 17-[(1-methylethylidene)bis (oxy)]-, (6α, 11β, 16α)-; its empirical formula is C 24 H 33 FO 6 . The structure is as follows: Each mL of Flurandrenolide Lotion, USP 0.05% contains 0.5 mg (1.145 μmol) (0.05%) flurandrenolide in an oil-in-water emulsion base composed of glycerin, cetyl alcohol, stearic acid, glyceryl monostearate, mineral oil, polyoxyl 40 stearate, menthol, benzyl alcohol, and purified water. structure
How Supplied
HOW SUPPLIED Flurandrenolide Lotion USP, 0.05% is supplied in plastic squeeze bottles as follows: 15 mL (NDC 24470-921-15) 60 mL (NDC 24470-921-60) 120 mL (NDC 24470-921-12) Keep out of reach of children. Storage: Avoid freezing. Keep tightly closed. Protect from light. Store at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). [See USP controlled room temperature] Manufactured by: Medical Products Laboratories Philadelphia, PA 19115 827620 v1 Rev. 10/17 Manufactured for: Cintex Services, LLC. 9330 LBJ Freeway, Suite 900 Dallas, TX 75243
Indications & Usage
INDICATIONS AND USAGE Flurandrenolide Lotion is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and Administration
DOSAGE AND ADMINISTRATION Shake well before using. A small quantity of Flurandrenolide Lotion should be rubbed gently into the affected area 2 or 3 times daily. Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Flurandrenolide Lotion should not be used with occlusive dressings unless directed by a physician. Tight-fitting diapers or plastic pants may constitute occlusive dressings.